IRCT20230309057660N1招募中Unknown
The effect of cognitive-behavioral intervention in reducing fear of COVID-19 symptoms, anxiety, depression, stress and improving the quality of life in people suffering from prolonged grief disorder due to the COVID-19
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 64 years（—）
- 性别
- All
入选标准
- •Being within the age range of 18 to 65 years old
- •Diagnosis of COVID-19 in an individual and the person is in the post-treatment recovery phase and also suffers from prolonged grief disorder
- •Willingness to participate in the project and obtaining informed consent
排除标准
- •Severe physical problems or visible organ impairment
- •Patients with major depressive disorder, psychosis, or major psychiatric disorders were not included in the study and only initial drug treatments were performed for them
研究者
相似试验
已完成
不适用
Impacts of Cognitive-Behavioral Intervention on Anxiety and Depression Among Social Science Education Students: A Randomized Controlled TrialJPRN-UMIN000034913Otusum Consult Training & Services55
已完成
不适用
Effect of a cognitive behavioral intervention with or without a Functional Capacity Evaluation on work ability in patients with musculoskeletal paiNL-OMON37815Condite70
已完成
不适用
The effect of cognitive behavioral intervention on mental health in Myocardial Infarction patients.Myocardial Infarction Disease.Acute Myocardial InfarctionIRCT2013111913568N2Kermanshah University of Medical Sciences30
已完成
不适用
Improving adherence to therapeutic regimen in hemodialysis patientsChronic renal disease.Chronic uremiaIRCT201211101599N21Vice chancellor for Research, Tehran University of Medical Sciences70
已完成
不适用
The effect of cognitive-behavioral intervention on the burden and quality of life in drug dependence caregivers referred to the Shahid Modarres Hospital in 2016Drug dependence.Mental and Behavioral Disorders due to use of alcohol,opioids,cannabissedatives, hypnotics, anxiolytics,cocaine,other stimulants, including caffeine,hallucinogens,nicotine,inhalants and other psychoactive substances and multiple drug useF10-19IRCT2017011431927N1Isfahan University of Medical Siences64